NKE Systematic Research
Nike's systematic screening reveals a marked compression in valuation multiples following a challenging period characterized by minimal top-line expansion and earnings contraction. Trading at $41.71 with a market capitalization of $61.9 billion, the stock currently sits near the bottom of its 52-week range ($40.00–$80.17), reflecting investor recalibration after revenue growth of just 0.19% year-over-year and EPS declining 2.83%.
The fundamental profile demonstrates several structural strengths despite cyclical headwinds. The company maintains a robust return on equity of 22.0%, significantly above typical consumer discretionary benchmarks, while the balance sheet exhibits prudent leverage with a debt-to-equity ratio of 0.53 and a healthy current ratio of 1.96. The gross margin of 42.91% underscores persistent pricing power in a brand portfolio that commands premium positioning across athletic footwear and apparel categories.
Systematic models flag notable concerns in operational momentum. The operating margin compressed to 8.18%, down from historical norms exceeding 12%, while the combination of flat revenue growth and negative earnings trajectory indicates margin pressure from inventory management challenges and competitive dynamics in key markets. The P/E ratio of 19.87x may appear reasonable relative to historical ranges, yet this multiple rests on a diminished earnings base with EPS of $2.10.
Within the peer framework encompassing DECK, CROX, and SHOO, Nike's research perspective centers on whether operational initiatives can restore growth momentum and margin expansion. The beta of 1.13 suggests moderate volatility characteristics, while the P/S ratio of 1.33x reflects market skepticism regarding near-term revenue acceleration potential relative to the company's established market leadership position.
Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.